The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

When is the optimal time to use bispecific antibodies in MM?

During the 2nd European Myeloma Network Meeting, the Multiple Myeloma Hub spoke to the steering committee member Hermann Einsele, Julius-Maximilians-Universität Würzburg, Würzburg, DE. We asked, When is the optimal time to use bispecific antibodies in MM?

When is the optimal time to use bispecific antibodies in MM?

In this video, Einsele discusses the best time to use bispecific antibodies in the treatment of multiple myeloma in terms of functionality of T cells. In addition, Einsele talks about how this may affect efficacy and toxicity in patients.

Share: